DBV Technologies S.A. financial data

Symbol
DBVT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
107 Avenue De La Republique, Chatillon, France
State of incorporation
France
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Apr 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 278 % -48.8%
Debt-to-equity 53.9 % +72.8%
Return On Equity -167 % -261%
Return On Assets -109 % -208%
Operating Margin -2.81K % -478%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137M shares +42%
Common Stock, Shares, Outstanding 103M shares
Entity Public Float 84.2M USD -54%
Common Stock, Value, Issued 11.7M USD +6.19%
Weighted Average Number of Shares Outstanding, Basic 97M shares +1.97%
Weighted Average Number of Shares Outstanding, Diluted 97M shares +1.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.15M USD -73.6%
Research and Development Expense 89.3M USD +48.4%
Selling and Marketing Expense 2.66M USD +9.07%
General and Administrative Expense 28.7M USD -2.58%
Operating Income (Loss) -117M USD -52.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -114M USD -56.6%
Income Tax Expense (Benefit) 55K USD +686%
Net Income (Loss) Attributable to Parent -114M USD -56.6%
Earnings Per Share, Basic -1.17 USD/shares -53.9%
Earnings Per Share, Diluted -1.17 USD/shares -53.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.5M USD -77%
Other Assets, Current 11.9M USD -32%
Assets, Current 44.4M USD -72.1%
Property, Plant and Equipment, Net 11.3M USD -10.4%
Operating Lease, Right-of-Use Asset 5.5M USD +4.86%
Intangible Assets, Net (Excluding Goodwill) 40K USD -31%
Other Assets, Noncurrent 4.42M USD -28%
Assets 65.7M USD -64.1%
Liabilities, Current 31.1M USD -16.6%
Operating Lease, Liability, Noncurrent 6.3M USD +39.1%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 38.3M USD -10.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 905K USD +22%
Retained Earnings (Accumulated Deficit) -286M USD -19.9%
Stockholders' Equity Attributable to Parent 27.4M USD -80.5%
Liabilities and Equity 65.7M USD -64.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -34.7M USD -66.5%
Net Cash Provided by (Used in) Financing Activities -62K USD -343%
Net Cash Provided by (Used in) Investing Activities -2.13M USD -5176%
Common Stock, Shares Authorized 103M shares +6.65%
Common Stock, Shares, Issued 103M shares +6.65%
Common Stock, Par or Stated Value Per Share 0.1 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -39.8M USD -136%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.5M USD -77%
Deferred Tax Assets, Valuation Allowance 325M USD +4.9%
Deferred Tax Assets, Gross 325M USD +4.9%
Operating Lease, Liability 6.95M USD +22.6%
Payments to Acquire Property, Plant, and Equipment 1.34M USD +1103%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -118M USD -75.9%
Lessee, Operating Lease, Liability, to be Paid 8.44M USD +15.7%
Property, Plant and Equipment, Gross 28.8M USD -8.85%
Operating Lease, Liability, Current 654K USD -42.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.23M USD +1537%
Lessee, Operating Lease, Liability, to be Paid, Year One 836K USD -34.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.49M USD -8.61%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.24M USD +194%
Deferred Tax Assets, Operating Loss Carryforwards 316M USD +2.99%
Operating Lease, Payments 501K USD +1.01%
Additional Paid in Capital 316M USD -16.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 1.59M USD +17.5%